Lobbying disclosures · Lobbying report
INSM: second_quarter 2026 lobbying report
MFN Issues.
Follow INSM- Became public
- Jul 17, 2026, 6:51 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 12:49 AM EST
Why this is connected
Legal-name match: INSMED INCORPORATED is INSMED Inc (https://www.sec.gov/Archives/edgar/data/1104506/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/dbbffba5-7c62-48c8-807f-272c824b5cfb/","filing_uuid":"dbbffba5-7c62-48c8-807f-272c824b5cfb","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/dbbffba5-7c62-48c8-807f-272c824b5cfb/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Beth Anne Cole","dt_posted":"2026-07-17T06:51:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2231 48th Street NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20007","registrant":{"id":401108183,"url":"https://lda.gov/api/v1/registrants/401108183/","house_registrant_id":56368,"name":"LMH STRATEGIC SOLUTIONS","description":null,"address_1":"2231 48th Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20007","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALANNA TEMME","contact_telephone":"+1 202-503-5189","dt_updated":"2026-07-09T12:14:41.865548-04:00"},"client":{"id":74123,"url":"https://lda.gov/api/v1/clients/74123/","client_id":74123,"name":"INSMED INCORPORATED","general_description":"Biopharmaceutical company.","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-06-01"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"MFN Issues.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":145804,"prefix":null,"prefix_display":null,"first_name":"ALANNA","nickname":null,"middle_name":null,"last_name":"TEMME","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, U.S. Representative Jon Porter","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in INSM
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Jul 7, 2026$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jun 10, 2026 · disclosed Jul 7, 2026 · Joint
- Nov 18, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Oct 3, 2025 · disclosed Nov 18, 2025 · filed 46 days later
- Oct 10, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Sep 22, 2025 · disclosed Oct 10, 2025
- Sep 12, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Aug 8, 2025 · disclosed Sep 12, 2025
- Aug 14, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jul 7, 2025 · disclosed Aug 14, 2025
- Jul 16, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jun 16, 2025 · disclosed Jul 16, 2025 · Joint
- May 14, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Apr 9, 2025 · disclosed May 14, 2025 · Joint
- Jul 9, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jun 21, 2024 · disclosed Jul 9, 2024 · Joint
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.